MLM
OGEN icon

Mount Lucas Management’s Oragenics OGEN Stock Holding History

Mount Lucas Management’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2
Closed -$16K – 163
2016
Q3 		$16K Hold
2
– – ﹤0.01% 157
2016
Q2 		$20K Buy
2
+1
+100% +$13.4K ﹤0.01% 139
2016
Q1 		$21K Buy
+1
New +$18.3K ﹤0.01% 116

Other funds holding OGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mount Lucas Management's OGEN Position: Q4 2016 in Review

Mount Lucas Management sold out of Oragenics (OGEN) in Q4 2016, closing a stake of 2 shares — an estimated $16K sold.

Mount Lucas Management first reported a position in OGEN in Q1 2016 and held it in 3 quarters. The position peaked at $21K in Q1 2016. 13 funds tracked by Wall St. Rank hold OGEN as of Q4 2016.

  • Mount Lucas Management reported no remaining Oragenics position as of Q4 2016 after selling out during the quarter.
  • Mount Lucas Management sold 2 Oragenics shares in Q4 2016, an estimated $16K.
  • Mount Lucas Management first reported a position in Oragenics in Q1 2016 and held it in 3 quarters.
  • Mount Lucas Management's Oragenics position peaked at $21K in Q1 2016.
  • 13 funds tracked by Wall St. Rank held Oragenics as of Q4 2016.

Based on Mount Lucas Management's 13F filing for Q4 2016, filed 14 Feb 2017.